Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 16-02-01 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 15-07-09 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.86M 1.71M 1.59M 3.02M 203M 3.07M 20.53M 7.98M 99.61M 7.99M 7.82M 343M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.89M 5.42M 5.05M 9.58M 642M 9.72M 65.04M 25.28M 316M 25.31M 24.77M 1.09B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 2015-03-31 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 2011-06-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 1991-05-28 |
Sidney Emery
BRD | Director/Board Member | 76 | 2005-10-02 |
| Director/Board Member | 59 | 2010-08-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -.--% | -.--% | 2.13K | ||
| +2.85% | +12.84% | -5.34% | +4.02% | 3.45B | ||
| +0.78% | -0.26% | +48.46% | +963.36% | 2.17B | ||
| +0.67% | +0.78% | -26.95% | -23.89% | 1.66B | ||
| -0.29% | -11.79% | +186.67% | +473.33% | 1.29B | ||
| +0.94% | +3.30% | -26.40% | +104.04% | 1.01B | ||
| -0.86% | +1.23% | +15.83% | +17.96% | 470M | ||
| +2.36% | +3.33% | +30.41% | +14.45% | 327M | ||
| +3.37% | +6.56% | +51.65% | +62.35% | 190M | ||
| +4.73% | +7.64% | +72.22% | +181.82% | 128M | ||
| Average | +1.33% | +3.25% | +34.66% | +179.75% | 1.07B | |
| Weighted average by Cap. | +1.22% | +4.74% | +27.45% | +264.59% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.41M 13.24M 12.34M 23.41M 1.57B 23.77M 159M 61.81M 771M 61.87M 60.55M 2.66B | 14.01M 12.25M 11.26M 10.49M 19.9M 1.33B 20.2M 135M 52.54M 656M 52.6M 51.47M 2.26B |
| Net income | -4.29M -3.75M -3.45M -3.21M -6.1M -409M -6.19M -41.4M -16.09M -201M -16.11M -15.76M -692M | -7.61M -6.65M -6.11M -5.7M -10.81M -724M -10.97M -73.38M -28.53M -356M -28.56M -27.94M -1.23B |
| Net Debt | 3.04M 2.66M 2.44M 2.28M 4.32M 290M 4.39M 29.35M 11.41M 142M 11.42M 11.18M 491M | 4.62M 4.03M 3.71M 3.46M 6.55M 439M 6.65M 44.51M 17.3M 216M 17.32M 16.95M 744M |
Employees
61
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















